Authors

Kapil N. Bhalla

Document Type

Patent

Publication Date

June 2010

Patent Number

7732476

Abstract

A method of inducing high anti-leukemia activity responsive to the combination of hydroxamic acid analogue histone deacetylase inhibitors and PKC412 against human acute leukemia characterized as expressing phosphorylated (p)FLT3 kinase by a novel flow cytometry-based assay.

Application Number

11/307,298

Assignees

University of South Florida

Filing Date

01/31/2006

Primary/U.S. Class

514/408

Share

COinS